Abstract
Development of a vaccine with enhanced efficacy compared to that of the Bacillus Calmette Guerin (BCG) vaccine is essential to reduce the global TB burden. This is challenging since an effective vaccine will need to induce protection that surpasses that induced by natural infection with M. tuberculosis and currently there are no identified biomarkers of protection. Nonetheless progress has been made over the last 20 years in the development and clinical evaluation of novel TB vaccines, evidenced by 15 candidate vaccines being tested in phase I clinical trials and 4 reaching phase IIb and III trials. In order to make further progress there is a need to further understanding of the interactions between M. tuberculosis and its host and for the development of ongoing partnerships to facilitate the design, harmonisation and funding of clinical trials.
Keywords: BCG, biomarker, correlates of protection, TB vaccine.
Current Respiratory Medicine Reviews
Title:Advances in TB Vaccinology
Volume: 9 Issue: 3
Author(s): Uta G. Hill and Clare R. Sander
Affiliation:
Keywords: BCG, biomarker, correlates of protection, TB vaccine.
Abstract: Development of a vaccine with enhanced efficacy compared to that of the Bacillus Calmette Guerin (BCG) vaccine is essential to reduce the global TB burden. This is challenging since an effective vaccine will need to induce protection that surpasses that induced by natural infection with M. tuberculosis and currently there are no identified biomarkers of protection. Nonetheless progress has been made over the last 20 years in the development and clinical evaluation of novel TB vaccines, evidenced by 15 candidate vaccines being tested in phase I clinical trials and 4 reaching phase IIb and III trials. In order to make further progress there is a need to further understanding of the interactions between M. tuberculosis and its host and for the development of ongoing partnerships to facilitate the design, harmonisation and funding of clinical trials.
Export Options
About this article
Cite this article as:
Hill G. Uta and Sander R. Clare, Advances in TB Vaccinology, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990021
DOI https://dx.doi.org/10.2174/1573398X113099990021 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Mechanism of Adjuvanticity of Aluminium-Containing Formulas
Current Pharmaceutical Design An Overview of Synthesis of Indole Alkaloids and Biological Activities of Secondary Metabolites Isolated from Hyrtios Species
Mini-Reviews in Medicinal Chemistry Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Current Signal Transduction Therapy Clinical Profile of Mortality among Chronic Schizophrenic Patients: A Local Pilot Survey in Iran
Current Psychiatry Research and Reviews Editorial [Hot topic: Structural Genomics (Executive Editor: Yu Wai Chen)]
Infectious Disorders - Drug Targets Molecular Dynamics Simulations of Protein Targets Identified in Mycobacterium tuberculosis
Current Medicinal Chemistry Targeting Cytokines: Production and Characterization of Anti-TNF-α scFvs by Phage Display Technology
Current Pharmaceutical Design Pyrrole: Chemical Synthesis, Microwave Assisted Synthesis, Reactions and Applications: A Review
Current Organic Chemistry Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy
Current Medicinal Chemistry Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery
Current Drug Targets Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Prevalence of Oral and Systemic Manifestations in Pediatric HIV Cohorts with and without Drug Therapy
Current HIV Research Kawasakis Disease, Acrodynia, and Mercury
Current Medicinal Chemistry Whole Cell Biocatalysts for the Preparation of Nucleosides and their Derivatives
Current Pharmaceutical Design Therapeutic HIV Vaccines
Current Topics in Medicinal Chemistry The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics
Current Respiratory Medicine Reviews Synthesis and Antibacterial Properties of Oxazolidinones and Oxazinanones
Anti-Infective Agents in Medicinal Chemistry